Events, Stories, Interviews, ...

Austrian Stock Talk 2022

May 4, 2022

Houskapreis 2022 "All Stars": Marinomed nominated

April 28, 2022

Marinomed was nominated again this year for the Houska Prize in the "All Stars" category and is delighted to receive an investment voucher worth EUR 10,000,-.

Read more about the Houska Prize "All Stars" 2022 here.

"GEWINN" Article: "Local biotech companies seek venture capital" (German Only)

January 21, 2022

Marinomed is featured in an article about Austria's biotech companies and the lack of risk-taking investors. Read the full article here.

© GEWINN 1/22
© GEWINN 1/22

CSO Eva Prieschl-Grassauer in an interview with "Health Europa" about "Broadening the scope of respiratory infection control"

January 20, 2022

Read the full interview here.

MDR "Wissen" Podcast: Nasal spray made from red algae can also protect against coronaviruses (German only)

November 26, 2021

CEO Andreas Grassauer in an interview with Börsenradio.at (German only)

November 24, 2021

The interview can be heard here.

Award Ceremony European Small and Mid-Cap Awards 2021

November 16, 2021

Marinomed is proud to be recognized as a runner-up in the "Star of Innovation" category of the European Small and Mid-Cap Awards 2021.

Marinomed at the 12th Landsteiner Tag

November 16, 2021

Marinomed was on site as a sponsor of the event on the topic: "The COVID-19 pandemic - as a driver of medical research". You can find a retrospect of the event here.

Photos: © Pauline Knibbe-Klimt, Marinomed

Houskapreis 2021: Inseln des Wissens (German only)

The Houska Award winners of the past 15 years talk about how success and failure are often very closely related in research. CSO Eva Prieschl-Grassauer speaks at minutes 13:47, 15:28, 20:45, 25:48, 27:45, 27:45; 28:36 and 30:53.

Award Ceremony BCG Gender Diversity Index Austria 2020

September 15, 2021

Marinomed has been elected to be the winner of the BCG Diversity Index Austria 2020 by Boston Consulting Group and trend.

Photo: BCG/Helmut Steiner

COLDAMARIS Plus at the 38th Vienna City Marathon

September 12, 2021

The Carragelose-containing nasal spray "COLDAMARIS Plus" is part of the hygiene concept of this year's Vienna City Marathon. More information can be found here.

Austria's Leading Companies (ALC) Awards: Winner's video

June 2021 - Marinomed Biotech AG is the winner of the "Research and Development" category

Vienna Stock Exchange Award 2021

June 18, 2021

The awarding of the Vienna Stock Exchange Prize - the most important award on the Austrian capital market - also took place in an exclusive setting in 2021. Marinomed won 3rd place in the "Mid-Cap" category. More information can be found here.

Austria’s Leading Companies (ALC) Award

For the 22nd time, the newspaper „Presse“, KSV1870 and PwC Austria awarded companies that make a lasting contribution to Austria's economy and location. Marinomed is the winner of the ALC Award in the category Research & Development. Find the whole article here. A clip of the award ceremony including a short interview with our CEO Andreas Grassauer (Min. 2:51) can be seen here.

KSV1870-CFO Hannes Frech (l.) congratulates Marinomed-CEO Andreas Grassauer (© Guenther Peroutka; Source: https://www.diepresse.com/5995131/alc-osterreich-die-sieger#slide-16)

Servus TV: "Servus am Abend" clip about Carragelose (German only)

April 28, 2021

ServusTV reported on Marinomed and the proven virus protection Carragelose. Carragelose is known as a well-tolerated, effective and safe means for the prevention and treatment of respiratory diseases. Increasingly, clinical data indicate that Carragelose also inactivates SARS-CoV-2. See the clip here.

Austrian Stock Talk 2021

CEO Andreas Grassauer talks about the company and presents recent figures and facts.

Interview with life-science Austria

The nasal spray against SARS-CoV-2 - Interview with Eva Prieschl-Grassauer (CSO) and Andreas Grassauer (CEO)

BioMarine Interview

BioMarine interviews CSO Eva Prieschl-Grassauer on Carragelose

Fighting autoimmune gastritis

November 2020

In cooperation with the Medical University of Vienna, Marinomed is developing a treatment for autoimmune gastritis. Read the article in the magazine Chemiereport (2020/7) or in their ePaper. (German only)

Interview with the magazine BÖRSIANER

October 2020

Eva Prieschl-Grassauer and Andreas Grassauer talk about SARS-CoV-2 and their assessment of a vaccination against the virus, as well as Marinomed and the history of Carragelose. You can find the interview in the 40th issue of the magazine and here (German only).

Interview with the magazine TREND

August 2020

Eva Prieschl-Grassauer and Andreas Grassauer talk about the Coronavirus, Carragelose and the future of Marinomed (issue 33/2020). Read the full article here (German only).

Vienna Stock Exchange Award 2020

June 17, 2020

The Vienna Stock Exchange Award is an annual event and the most important award for Austrian Companies. You can find more information here.

Börsen Radio Interview with Wolfgang Matejka

November 11, 2019

©Börsen Radio Network AG

Interview with Erste Group

May 16, 2019

IPO of Marinomed Biotech AG

February 1, 2019